BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 32471869)

  • 1. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination.
    Min YQ; Ning YJ; Wang H; Deng F
    J Biol Chem; 2020 Jul; 295(28):9691-9711. PubMed ID: 32471869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling.
    Ban J; Lee NR; Lee NJ; Lee JK; Quan FS; Inn KS
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30558248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
    Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.
    Atkinson SC; Heaton SM; Audsley MD; Kleifeld O; Borg NA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses.
    Santiago FW; Covaleda LM; Sanchez-Aparicio MT; Silvas JA; Diaz-Vizarreta AC; Patel JR; Popov V; Yu XJ; García-Sastre A; Aguilar PV
    J Virol; 2014 Apr; 88(8):4572-85. PubMed ID: 24478431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.
    Oshiumi H; Miyashita M; Matsumoto M; Seya T
    PLoS Pathog; 2013; 9(8):e1003533. PubMed ID: 23950712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonstructural Protein of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Inhibits TBK1 to Evade Interferon-Mediated Response.
    Lee JK; Shin OS
    J Microbiol Biotechnol; 2021 Feb; 31(2):226-232. PubMed ID: 33397830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25.
    Pauli EK; Chan YK; Davis ME; Gableske S; Wang MK; Feister KF; Gack MU
    Sci Signal; 2014 Jan; 7(307):ra3. PubMed ID: 24399297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Conserved Amino Acids within the NSs of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Are Essential for Anti-interferon Activity.
    Moriyama M; Igarashi M; Koshiba T; Irie T; Takada A; Ichinohe T
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foot-and-Mouth Disease Virus 3B Protein Interacts with Pattern Recognition Receptor RIG-I to Block RIG-I-Mediated Immune Signaling and Inhibit Host Antiviral Response.
    Zhang X; Zhu Z; Wang C; Yang F; Cao W; Li P; Du X; Zhao F; Liu X; Zheng H
    J Immunol; 2020 Oct; 205(8):2207-2221. PubMed ID: 32917788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling.
    Sánchez-Aparicio MT; Feinman LJ; García-Sastre A; Shaw ML
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses.
    Hayman TJ; Hsu AC; Kolesnik TB; Dagley LF; Willemsen J; Tate MD; Baker PJ; Kershaw NJ; Kedzierski L; Webb AI; Wark PA; Kedzierska K; Masters SL; Belz GT; Binder M; Hansbro PM; Nicola NA; Nicholson SE
    Immunol Cell Biol; 2019 Oct; 97(9):840-852. PubMed ID: 31335993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.
    Shu XS; Zhao Y; Sun Y; Zhong L; Cheng Y; Zhang Y; Ning K; Tao Q; Wang Y; Ying Y
    J Pathol; 2018 Jan; 244(1):36-48. PubMed ID: 28940253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein.
    Rajsbaum R; Albrecht RA; Wang MK; Maharaj NP; Versteeg GA; Nistal-Villán E; García-Sastre A; Gack MU
    PLoS Pathog; 2012; 8(11):e1003059. PubMed ID: 23209422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I.
    Zhao C; Jia M; Song H; Yu Z; Wang W; Li Q; Zhang L; Zhao W; Cao X
    Cell Rep; 2017 Nov; 21(6):1613-1623. PubMed ID: 29117565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction.
    Ning YJ; Feng K; Min YQ; Deng F; Hu Z; Wang H
    J Biol Chem; 2017 Oct; 292(40):16722-16733. PubMed ID: 28848048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    Chang CY; Liu HM; Chang MF; Chang SC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform.
    Ning YJ; Wang M; Deng M; Shen S; Liu W; Cao WC; Deng F; Wang YY; Hu Z; Wang H
    J Mol Cell Biol; 2014 Aug; 6(4):324-37. PubMed ID: 24706939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the Underlying Interaction Mechanism Between
    Zhou CM; Yu XJ
    Front Immunol; 2021; 12():676861. PubMed ID: 34122440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.